✦ LIBER ✦

Survival of Clostridium perfringens sepsis in a liver transplant recipient

✍ Scribed by Geraldine C. Diaz; Thomas Boyer; John F. Renz

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 81 KB
Volume: 15
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21855

No coin nor oath required. For personal study only.

✦ Synopsis

Clostridium perfringens sepsis following orthotopic liver transplantation (OLT) is a rare but reported complication that historically results in mortality or emergent retransplantation (ReTx). Complications from C. perfringens emphysematous gastritis have contributed to the death of a healthy live liver donor as well. Herein, we describe the first documented survivor of C. perfringens sepsis following OLT managed without laparotomy or emergent ReTx.

📜 SIMILAR VOLUMES

Recurrence of nonalcoholic steatohepatit

Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient

✍ Carson, K ;Washington, M K ;Treem, W R ;Clavien, P A ;Hunt, C M 📂 Article 📅 1997 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 180 KB 👁 1 views

A 42-year-old white man with morbid obesity and hypertriglyceridemia was noted to have nonalcoholic steatohepatitis (NASH) at the time of a laparoscopic cholecystectomy for presumed gallstone pancreatitis. His postoperative course was complicated by a 50-kg weight loss and continued right upper quad

Successful treatment of cerebral tubercu

Successful treatment of cerebral tuberculosis in a liver transplant recipient

✍ Sonal Asthana; Glenn K. Bonney; Ashley Guthrie; Mervyn H. Davies; K. Rajendra Pr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

Liver transplant recipient survival bene

Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era

✍ Carl L. Berg; Robert M. Merion; Tempie H. Shearon; Kim M. Olthoff; Robert S. Bro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

Receipt of a living donor liver transplant (LDLT) has been associated with improved survival compared with waiting for a deceased donor liver transplant (DDLT). However, the survival benefit of liver transplant has been questioned for candidates with Model for Endstage Liver Disease (MELD) scores <1

The pediatric end-stage liver disease (P

The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients

✍ Neal R. Barshes; Timothy C. Lee; Ian W. Udell; Christine A. O'Mahoney; Saul J. K 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

The pediatric end-stage liver disease (PELD) model accurately estimates 90-day waitlist mortality for pediatric liver transplant candidates, but it has been unclear if PELD can identify patients who will derive survival benefit from undergoing liver transplantation (LT), if it correlates with posttr

Complications of liver biopsy in liver t

Complications of liver biopsy in liver transplant patients: Increased sepsis associated with choledochojejunostomy

✍ Mark E. Bubak; Michael K. Porayko; Ruud A. F. Krom; Russell H. Wiesner 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB

We investigated the incidence and types of liver biopsy complications in our first 160 consecutive liver transplantations. A significant complication was identified by the need for therapeutic intervention (for example, hospitalization, transfusion, intravenous fluids, chest tube, surgery or antibio

Abnormal liver function tests in a liver

Abnormal liver function tests in a liver transplant recipient with hepatitis B virus: Report of a case

✍ Timothy McCashland 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 1 views

A 44-year-old white man was diagnosed with chronic hepatitis B in 1999 by his primary-care physician. His laboratory results were as follows: aspartate aminotransferase (AST) 144 IU/L, alanine aminotransferase (ALT) 82 IU/L, hepatitis B surface antigen (HBsAg) positive, hepatitis B e antigen (HBeAg)